S&P 500   3,585.62 (-1.51%)
DOW   28,725.51 (-1.71%)
QQQ   267.26 (-1.70%)
AAPL   138.20 (-3.00%)
MSFT   232.90 (-1.94%)
META   135.68 (-0.54%)
GOOGL   95.65 (-1.82%)
AMZN   113.00 (-1.57%)
TSLA   265.25 (-1.10%)
NVDA   121.39 (-0.66%)
NIO   15.77 (+1.22%)
BABA   79.99 (+1.18%)
AMD   63.36 (-1.22%)
T   15.34 (-1.22%)
MU   50.10 (+0.18%)
CGC   2.73 (-1.80%)
F   11.20 (-2.35%)
GE   61.91 (-1.31%)
DIS   94.33 (-3.20%)
AMC   6.97 (-1.83%)
PYPL   86.07 (-2.97%)
PFE   43.76 (-0.91%)
NFLX   235.44 (-1.78%)
S&P 500   3,585.62 (-1.51%)
DOW   28,725.51 (-1.71%)
QQQ   267.26 (-1.70%)
AAPL   138.20 (-3.00%)
MSFT   232.90 (-1.94%)
META   135.68 (-0.54%)
GOOGL   95.65 (-1.82%)
AMZN   113.00 (-1.57%)
TSLA   265.25 (-1.10%)
NVDA   121.39 (-0.66%)
NIO   15.77 (+1.22%)
BABA   79.99 (+1.18%)
AMD   63.36 (-1.22%)
T   15.34 (-1.22%)
MU   50.10 (+0.18%)
CGC   2.73 (-1.80%)
F   11.20 (-2.35%)
GE   61.91 (-1.31%)
DIS   94.33 (-3.20%)
AMC   6.97 (-1.83%)
PYPL   86.07 (-2.97%)
PFE   43.76 (-0.91%)
NFLX   235.44 (-1.78%)
S&P 500   3,585.62 (-1.51%)
DOW   28,725.51 (-1.71%)
QQQ   267.26 (-1.70%)
AAPL   138.20 (-3.00%)
MSFT   232.90 (-1.94%)
META   135.68 (-0.54%)
GOOGL   95.65 (-1.82%)
AMZN   113.00 (-1.57%)
TSLA   265.25 (-1.10%)
NVDA   121.39 (-0.66%)
NIO   15.77 (+1.22%)
BABA   79.99 (+1.18%)
AMD   63.36 (-1.22%)
T   15.34 (-1.22%)
MU   50.10 (+0.18%)
CGC   2.73 (-1.80%)
F   11.20 (-2.35%)
GE   61.91 (-1.31%)
DIS   94.33 (-3.20%)
AMC   6.97 (-1.83%)
PYPL   86.07 (-2.97%)
PFE   43.76 (-0.91%)
NFLX   235.44 (-1.78%)
S&P 500   3,585.62 (-1.51%)
DOW   28,725.51 (-1.71%)
QQQ   267.26 (-1.70%)
AAPL   138.20 (-3.00%)
MSFT   232.90 (-1.94%)
META   135.68 (-0.54%)
GOOGL   95.65 (-1.82%)
AMZN   113.00 (-1.57%)
TSLA   265.25 (-1.10%)
NVDA   121.39 (-0.66%)
NIO   15.77 (+1.22%)
BABA   79.99 (+1.18%)
AMD   63.36 (-1.22%)
T   15.34 (-1.22%)
MU   50.10 (+0.18%)
CGC   2.73 (-1.80%)
F   11.20 (-2.35%)
GE   61.91 (-1.31%)
DIS   94.33 (-3.20%)
AMC   6.97 (-1.83%)
PYPL   86.07 (-2.97%)
PFE   43.76 (-0.91%)
NFLX   235.44 (-1.78%)
NYSE:BXC

BlueLinx - BXC Stock Forecast, Price & News

$62.10
+0.98 (+1.60%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$60.30
$63.96
50-Day Range
$57.88
$83.07
52-Week Range
$45.86
$100.01
Volume
119,771 shs
Average Volume
160,523 shs
Market Capitalization
$599.76 million
P/E Ratio
1.90
Dividend Yield
N/A
Price Target
$104.75

BlueLinx MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
68.7% Upside
$104.75 Price Target
Short Interest
Bearish
5.71% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-48.53%
From $29.26 to $15.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Construction Sector

81st out of 106 stocks

Lumber, Plywood, & Millwork Industry

1st out of 1 stocks

BXC stock logo

About BlueLinx (NYSE:BXC) Stock

BlueLinx Holdings Inc., together with its subsidiaries, distributes residential and commercial building products in the United States. The company distributes specialty products comprising engineered wood, industrial products, cedar, moulding, siding, metal, and insulation products; and structural products include lumber, plywood, oriented strand boards, rebars and remesh, spruce, and other wood products primarily that are used for structural support in construction projects. It also provides various value-added services and solutions to customers and suppliers. The company serves dealers, specialty distributors, national home centers, and manufactured housing customers through a network of distribution centers. BlueLinx Holdings Inc. was incorporated in 2004 and is headquartered in Marietta, Georgia.

Receive BXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.

BXC Stock News Headlines

Bluelinx Holdings Inc
BlueLinx Announces Second Quarter 2022 Results
See More Headlines
Receive BXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.

BXC Company Calendar

Last Earnings
8/02/2022
Today
9/30/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Lumber, plywood, & millwork
Sub-Industry
Trading Companies & Distributors
CUSIP
09624H10
Employees
2,055
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$104.75
High Stock Price Forecast
$127.00
Low Stock Price Forecast
$75.00
Forecasted Upside/Downside
+68.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$296.13 million
Pretax Margin
9.70%

Debt

Sales & Book Value

Annual Sales
$4.28 billion
Cash Flow
$32.68 per share
Book Value
$37.42 per share

Miscellaneous

Free Float
9,214,000
Market Cap
$599.76 million
Optionable
Optionable
Beta
1.87

Key Executives

  • Mr. Dwight Audley Konrad Gibson (Age 47)
    Pres, CEO & Director
    Comp: $1.43M
  • Ms. Kelly Cunningham Janzen (Age 49)
    CFO, Treasurer & Sr. VP
    Comp: $1.3M
  • Mr. Shyam K. ReddyMr. Shyam K. Reddy (Age 47)
    Sr. VP, Chief Legal & Sustainability Officer and Corp. Sec.
    Comp: $1.27M
  • Mr. Mitchell B. LewisMr. Mitchell B. Lewis (Age 60)
    Director
    Comp: $2.16M
  • Mr. Adam K. Bowen (Age 39)
    VP & Chief Accounting Officer
  • Mr. Ryan A. Taylor (Age 45)
    VP of Investor Relations & Treasury
  • Seth Freeman
    VP of Marketing & Communications
  • Mr. Sean Dwyer
    Chief Strategy & Corp. Devel. Officer
  • Mr. Kevin Alan Henry (Age 54)
    Chief People Officer
  • Mr. Michael Wilson (Age 59)
    Sr. VP of Product Management













BXC Stock - Frequently Asked Questions

Should I buy or sell BlueLinx stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BXC shares.
View BXC analyst ratings
or view top-rated stocks.

What is BlueLinx's stock price forecast for 2022?

5 equities research analysts have issued twelve-month price objectives for BlueLinx's shares. Their BXC share price forecasts range from $75.00 to $127.00. On average, they anticipate the company's stock price to reach $104.75 in the next twelve months. This suggests a possible upside of 64.6% from the stock's current price.
View analysts price targets for BXC
or view top-rated stocks among Wall Street analysts.

How have BXC shares performed in 2022?

BlueLinx's stock was trading at $95.76 at the beginning of the year. Since then, BXC stock has decreased by 33.5% and is now trading at $63.65.
View the best growth stocks for 2022 here
.

Are investors shorting BlueLinx?

BlueLinx saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 470,800 shares, an increase of 5.5% from the July 31st total of 446,100 shares. Based on an average trading volume of 168,200 shares, the days-to-cover ratio is presently 2.8 days. Currently, 5.2% of the company's stock are sold short.
View BlueLinx's Short Interest
.

When is BlueLinx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our BXC earnings forecast
.

How were BlueLinx's earnings last quarter?

BlueLinx Holdings Inc. (NYSE:BXC) announced its earnings results on Tuesday, August, 2nd. The construction company reported $7.48 earnings per share for the quarter, missing analysts' consensus estimates of $7.64 by $0.16. BlueLinx had a trailing twelve-month return on equity of 79.52% and a net margin of 7.26%. During the same quarter in the prior year, the firm posted $11.61 EPS.

What is Mitch Lewis' approval rating as BlueLinx's CEO?

56 employees have rated BlueLinx Chief Executive Officer Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among the company's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlueLinx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), Nautilus (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

What is BlueLinx's stock symbol?

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

How do I buy shares of BlueLinx?

Shares of BXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlueLinx's stock price today?

One share of BXC stock can currently be purchased for approximately $63.65.

How much money does BlueLinx make?

BlueLinx (NYSE:BXC) has a market capitalization of $614.86 million and generates $4.28 billion in revenue each year. The construction company earns $296.13 million in net income (profit) each year or $32.71 on an earnings per share basis.

How many employees does BlueLinx have?

The company employs 2,055 workers across the globe.

How can I contact BlueLinx?

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The official website for the company is www.bluelinxco.com. The construction company can be reached via phone at (770) 953-7000, via email at ir@audentestx.com, or via fax at 770-221-8902.

This page (NYSE:BXC) was last updated on 9/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.